Cargando…
PReS-FINAL-2030: Treatment with leflunomide results in a higher flare rate of chronic uveitis compared to methotrexate in patients with juvenile idiopathic arthritis treated with both drugs
Autores principales: | Bichler, J, Krumrey-Langkammerer, M, Haas, JP, Hugle, B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044115/ http://dx.doi.org/10.1186/1546-0096-11-S2-P43 |
Ejemplares similares
-
Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication
por: Hügle, Boris, et al.
Publicado: (2021) -
PReS-FINAL-2048: Treatment with methotrexate plus leflunomide for juvenile idiopathic arthritis
por: Quesada-Masachs, E, et al.
Publicado: (2013) -
PReS-FINAL-2094: Evaluation of the benefits of sequential addition of leflunomide in patients with polyarticular course juvenile idiopathic arthritis failing standard dose methotrexate
por: Chickermane, PR, et al.
Publicado: (2013) -
Salivary gland ultrasound in the diagnostic workup of juvenile Sjögren’s syndrome and mixed connective tissue disease
por: Krumrey-Langkammerer, Manuela, et al.
Publicado: (2020) -
PReS-FINAL-2031: Hyaluronic acid is a marker of active arthritis, but not systemic inflammation in systemic juvenile idiopathic arthritis
por: Hugle, B, et al.
Publicado: (2013)